Atlas Trials

Clinical Study Evaluating Safety of Pentoxifylline and Celecoxib in Patients With Grand-Mal Epilepsy Treated by Phenytoin Monotherapy

Clinical trial NCT05637086 · RECRUITING

Trial details

NCT number
NCT05637086
Sponsor
Mostafa Bahaa
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Epilepsy
Start date
2022-12-20
Primary completion
2026-12-20
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.